P-Cure Ltd. is a company founded in early 2007 that has developed a comprehensive patient-centric proton therapy solution with clinical benefits and financial advantages. P-Cure's mission is to provide proton therapy with greater treatment precision, enhanced clinical outcomes, and expanded treatment options. By significantly reducing the capital and operating costs, P-Cure expands the availability of proton therapy to all cancer care institutions and new facility developers worldwide. The company's commitment is to prioritize patient needs in the delivery of proton therapy.